STATINS AND MYOPATHY: MOLECULAR MECHANISMS
<p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 ap...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | http://www.rpcardio.ru/jour/article/view/472 |
| _version_ | 1797762999343120384 |
|---|---|
| author | O. M. Drapkina E. M. Chernova O. N. Korneeva |
| author_facet | O. M. Drapkina E. M. Chernova O. N. Korneeva |
| author_sort | O. M. Drapkina |
| collection | DOAJ |
| description | <p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered. </p> |
| first_indexed | 2024-03-12T19:36:18Z |
| format | Article |
| id | doaj.art-42ec33ef7e4b476ba4e1be1176209394 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-03-12T19:36:18Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-42ec33ef7e4b476ba4e1be11762093942023-08-02T04:09:49ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018346947310.1234/1819-6446-2012-3-469-473472STATINS AND MYOPATHY: MOLECULAR MECHANISMSO. M. Drapkina0E. M. Chernova1O. N. Korneeva2Первый Московский государственный медицинский университет им. И.М.СеченоваПервый Московский государственный медицинский университет им. И.М.СеченоваПервый Московский государственный медицинский университет им. И.М.Сеченова<p>The safety of statin therapy is considered. In particular the reasons of a complication such as myopathy are discussed in detail. The molecular mechanisms of statin myopathy , as well as its risk factors are presented. The role of coenzyme Q10 in the myopathy development and coenzyme Q10 application for the prevention of this complication are considered. </p>http://www.rpcardio.ru/jour/article/view/472статинымиопатиякоэнзим Q10розувастатин |
| spellingShingle | O. M. Drapkina E. M. Chernova O. N. Korneeva STATINS AND MYOPATHY: MOLECULAR MECHANISMS Рациональная фармакотерапия в кардиологии статины миопатия коэнзим Q10 розувастатин |
| title | STATINS AND MYOPATHY: MOLECULAR MECHANISMS |
| title_full | STATINS AND MYOPATHY: MOLECULAR MECHANISMS |
| title_fullStr | STATINS AND MYOPATHY: MOLECULAR MECHANISMS |
| title_full_unstemmed | STATINS AND MYOPATHY: MOLECULAR MECHANISMS |
| title_short | STATINS AND MYOPATHY: MOLECULAR MECHANISMS |
| title_sort | statins and myopathy molecular mechanisms |
| topic | статины миопатия коэнзим Q10 розувастатин |
| url | http://www.rpcardio.ru/jour/article/view/472 |
| work_keys_str_mv | AT omdrapkina statinsandmyopathymolecularmechanisms AT emchernova statinsandmyopathymolecularmechanisms AT onkorneeva statinsandmyopathymolecularmechanisms |